From: J on
Gemcitabine, Rituximab, Oxaliplatin, and Pegfilgrastim Active for Relapsed
NHL
http://professional.cancerconsultants.com/conferencecoverage.aspx?id=42219

[Excerpt]

Gemcitabine, Rituximab, Oxaliplatin, and Pegfilgrastim Active for Relapsed
NHL

Researchers from the M.D. Anderson Cancer Center have reported that the
combination of gemcitabine, rituximab, oxaliplatin, and pegfilgrastim
compares favorably with other salvage regimens for relapsed non-Hodgkin�s
lymphoma (NHL) and is less toxic. The details of this study were presented
at the 2008 meeting of the American Society of Clinical Oncology in
Chicago May 30-June 2.1

[see web page]